We are live on ! Find out more
INVA icon

Innoviva

233 hedge funds and large institutions have $1.38B invested in Innoviva in 2018 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 80 increasing their positions, 72 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,056% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $2.37M

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

100% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 22

20% more capital invested

Capital invested by funds: $1.14B → $1.38B (+$233M)

11% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 72

10% more funds holding

Funds holding: 211233 (+22)

5.37% more ownership

Funds ownership: 73.85%79.22% (+5.4%)

Holders
233
Holders Change
+22
Holders Change %
+10.43%
% of All Funds
5.19%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
44
Increased
80
Reduced
72
Closed
22
Calls
$27.4M
Puts
$2.37M
Net Calls
+$25M
Net Calls Change
+$21.1M
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
Penserra Capital Management
California
$10.9M +$10.1M +621,906 New
Principal Financial Group
27
Principal Financial Group
Iowa
$10.6M +$102K +6,266 +1%
Charles Schwab
28
Charles Schwab
California
$10.5M -$2.07M -127,471 -18%
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
$9.09M -$5.38M -331,562 -39%
CEP
30
Chicago Equity Partners
Illinois
$8.7M -$713K -43,900 -8%
SIM
31
Spark Investment Management
New York
$8.62M -$1.26M -77,800 -14%
Victory Capital Management
32
Victory Capital Management
Texas
$7.71M -$548K -33,759 -7%
Ameriprise
33
Ameriprise
Minnesota
$7.18M -$29.3K -1,805 -0.4%
TCIM
34
TIAA CREF Investment Management
New York
$6.89M -$98.5K -6,065 -2%
AL
35
AJO LP
Pennsylvania
$6.86M -$2.11M -129,916 -25%
UBS Group
36
UBS Group
Switzerland
$6.46M +$5.92M +364,488 +6,102%
Morgan Stanley
37
Morgan Stanley
New York
$6.44M -$5.23M -322,034 -47%
BGIM
38
Brandywine Global Investment Management
Pennsylvania
$6.21M +$219K +13,481 +4%
Arrowstreet Capital
39
Arrowstreet Capital
Massachusetts
$6.13M +$2.02M +124,384 +55%
CAM
40
ClariVest Asset Management
California
$5.93M +$1.41M +86,604 +34%
Millennium Management
41
Millennium Management
New York
$5.67M +$3.81M +234,439 +260%
Two Sigma Investments
42
Two Sigma Investments
New York
$5.25M +$4.89M +300,877 New
SG Americas Securities
43
SG Americas Securities
New York
$5.21M +$4.85M +298,446 New
GAM
44
Gotham Asset Management
New York
$5.12M -$1.38M -85,209 -23%
MPM
45
Meritage Portfolio Management
Kansas
$5.02M -$109K -6,685 -2%
APG Asset Management
46
APG Asset Management
Netherlands
$5.01M +$4.54M +279,800 +577%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$4.79M +$1.46M +89,600 +49%
PPA
48
Parametric Portfolio Associates
Washington
$4.47M +$612K +37,683 +17%
KC
49
Kepos Capital
New York
$4.45M +$4.14M +254,787 New
Robeco Institutional Asset Management
50
Robeco Institutional Asset Management
Netherlands
$4.3M +$546K +33,614 +16%

INVA Hedge Fund Activity: Q4 2018 in Review

233 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2018, worth a combined $1.38B — up 20% from $1.14B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new INVA positions and 22 closed out — a net gain of 22 holders — while 80 added to existing stakes and 72 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $22.9M. The largest seller was JP Morgan Chase, cutting an estimated $16.2M.

  • 233 institutional investors held Innoviva (INVA) as of Q4 2018, up from 211 in Q3 2018.
  • Funds reported $1.38B of Innoviva stock for Q4 2018, up 20% quarter-over-quarter.
  • 44 funds opened new Innoviva positions in Q4 2018 and 22 closed out, a net change of +22 holders.
  • The largest Innoviva buyer in Q4 2018 was Renaissance Technologies, an estimated $22.9M added.
  • The largest Innoviva seller in Q4 2018 was JP Morgan Chase, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2018.